Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study. [PDF]
Ishikawa H, Oka K, Inoue H.
europepmc +1 more source
An update on posterior-approach blepharoptosis surgery: Influence of clinical factors on surgical outcomes. [PDF]
Nowak-Gospodarowicz I +3 more
europepmc +1 more source
Subbrow Blepharoplasty to Augment Blepharoptosis Repair in East Asian Patients. [PDF]
Looi A, Tan L.
europepmc +1 more source
Surgical Outcomes of Blepharoptosis in Ocular Prosthesis Patients. [PDF]
Ulas MG +5 more
europepmc +1 more source
Artificial intelligence-driven virtual reality eye-tracking for the objective measurement of MRD1 and MRD2 in blepharoptosis. [PDF]
Savant R +17 more
europepmc +1 more source
Ultrasound-guided preseptal hydrodissection with 5% dextrose in water for persistent botulinum toxin-associated ptosis: a technical protocol. [PDF]
Lam KHS +5 more
europepmc +1 more source
Iatrogenic Blepharoptosis: Multimodal Management and Treatment Technique With Botulinum Toxin Type A. [PDF]
Jaime Alberto RP +3 more
europepmc +1 more source
A unique cause of blepharoptosis associated with <i>RYR1</i> mutation. [PDF]
Samai IM, Wong BR.
europepmc +1 more source
Periorbital Changes Following Glucagon-Like Peptide-1 Receptor Agonist Use: A Retrospective Cohort Study of Oculofacial Complications and Interventions. [PDF]
Saffari PS +4 more
europepmc +1 more source
Functional and Cosmetic Outcomes of Müller Muscle-Conjunctival Resection in Selected Pediatric Ptosis Patients with a Positive Phenylephrine Test. [PDF]
Ulas MG +4 more
europepmc +1 more source

